Counterpoint Quantitative Equity ETF (NYSE:CPAI) Stock Short Interest Report for September

Counterpoint Quantitative Equity ETF (NYSE:CPAI – Get Free Report) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 63,048 shares, a growth of 347.2% from the September 15th total of 14,099 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 70,933 shares, the short-interest ratio is presently 0.9 days.

Institutional Investors Weigh In On Counterpoint Quantitative Equity ETF

Several hedge funds have recently added to or reduced their stakes in the stock. Counterpoint Mutual Funds LLC grew its stake in shares of Counterpoint Quantitative Equity ETF by 5.3% in the first quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock worth $64,758,000 after acquiring an additional 78,500 shares during the last quarter. Nilsine Partners LLC increased its stake in Counterpoint Quantitative Equity ETF by 3.6% during the 2nd quarter. Nilsine Partners LLC now owns 229,706 shares of the company’s stock valued at $11,936,000 after purchasing an additional 8,084 shares in the last quarter. NewEdge Advisors LLC raised its holdings in Counterpoint Quantitative Equity ETF by 230.6% in the second quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock worth $5,782,000 after buying an additional 77,610 shares during the last quarter. Cetera Investment Advisers raised its holdings in Counterpoint Quantitative Equity ETF by 65.1% in the first quarter. Cetera Investment Advisers now owns 107,891 shares of the company’s stock worth $4,509,000 after buying an additional 42,559 shares during the last quarter. Finally, Concurrent Investment Advisors LLC raised its holdings in Counterpoint Quantitative Equity ETF by 8.2% in the second quarter. Concurrent Investment Advisors LLC now owns 100,854 shares of the company’s stock worth $5,240,000 after buying an additional 7,641 shares during the last quarter.

Counterpoint Quantitative Equity ETF Price Performance

CPAI stock traded down $0.09 on Friday, reaching $53.26. 207,559 shares of the company traded hands, compared to its average volume of 58,079. Counterpoint Quantitative Equity ETF has a one year low of $37.29 and a one year high of $53.96. The company has a market cap of $493.20 million, a P/E ratio of -63,862.11 and a beta of 1.18. The firm has a fifty day simple moving average of $52.19 and a 200-day simple moving average of $49.55.

About Counterpoint Quantitative Equity ETF

(Get Free Report)

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.

Further Reading

Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.